Literature DB >> 19412012

Hepatocellular carcinoma in 2 young adolescents with chronic hepatitis C.

Regino P González-Peralta1, Max R Langham, Joel M Andres, Parvathi Mohan, Paul M Colombani, Mary K Alford, Kathleen B Schwarz.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19412012     DOI： 10.1097/MPG.0b013e318170af04

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  31 in total

1.  The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C.

Authors:  Kathleen B Schwarz; Regino P Gonzalez-Peralta; Karen F Murray; Jean P Molleston; Barbara A Haber; Maureen M Jonas; Philip Rosenthal; Parvathi Mohan; William F Balistreri; Michael R Narkewicz; Lesley Smith; Steven J Lobritto; Stephen Rossi; Alexandra Valsamakis; Zachary Goodman; Patricia R Robuck; Bruce A Barton
Journal:  Gastroenterology       Date:  2010-10-28       Impact factor: 22.682

Review 2.  Cirrhosis in children and adolescents: An overview.

Authors:  Raquel Borges Pinto; Ana Claudia Reis Schneider; Themis Reverbel da Silveira
Journal:  World J Hepatol       Date:  2015-03-27

Review 3.  The long-term horizon: Patients who will remain untreated in the era of triple therapy.

Authors:  Andrew Aronsohn; Donald Jensen
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-03-06

Review 4.  Hepatitis B and C.

Authors:  Wikrom Karnsakul; Kathleen B Schwarz
Journal:  Pediatr Clin North Am       Date:  2017-06       Impact factor: 3.278

5.  Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trial.

Authors:  Maureen M Jonas; William Balistreri; Regino P Gonzalez-Peralta; Barbara Haber; Steven Lobritto; Parvathi Mohan; Jean P Molleston; Karen F Murray; Michael R Narkewicz; Philip Rosenthal; Kathleen B Schwarz; Bruce A Barton; John A Shepherd; Paul D Mitchell; Christopher Duggan
Journal:  Hepatology       Date:  2012-07-06       Impact factor: 17.425

Review 6.  Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.

Authors:  Pankaj Puri; Vivek A Saraswat; Radha K Dhiman; Anil C Anand; Subrat K Acharya; Shivaram P Singh; Yogesh K Chawla; Deepak N Amarapurkar; Ajay Kumar; Anil Arora; Vinod K Dixit; Abraham Koshy; Ajit Sood; Ajay Duseja; Dharmesh Kapoor; Kaushal Madan; Anshu Srivastava; Ashish Kumar; Manav Wadhawan; Amit Goel; Abhai Verma; Gaurav Pandey; Rohan Malik; Swastik Agrawal
Journal:  J Clin Exp Hepatol       Date:  2016-07-02

7.  Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children.

Authors:  James R Rodrigue; William Balistreri; Barbara Haber; Maureen M Jonas; Parvathi Mohan; Jean P Molleston; Karen F Murray; Michael R Narkewicz; Philip Rosenthal; Lesley J Smith; Steven J Lobritto; Kathleen B Schwarz; Patricia R Robuck; Bruce Barton; Regino P González-Peralta
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

8.  Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study.

Authors:  Parvathi Mohan; Bruce A Barton; Michael R Narkewicz; Jean P Molleston; Regino P Gonzalez-Peralta; Philip Rosenthal; Karen F Murray; Barbara Haber; Kathleen B Schwarz; Zachary D Goodman
Journal:  Hepatology       Date:  2013-09-30       Impact factor: 17.425

Review 9.  Hepatitis B and C in Children.

Authors:  Rohan Malik; Winita Hardikar
Journal:  Indian J Pediatr       Date:  2016-04-20       Impact factor: 1.967

10.  Managing pediatric hepatitis C: current and emerging treatment options.

Authors:  Wikrom Karnsakul; Mary Kay Alford; Kathleen B Schwarz
Journal:  Ther Clin Risk Manag       Date:  2009-08-20       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.